CFO4Life Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $459K | Sell |
1,306
-629
| -33% | -$224K | 0.07% | 129 |
|
|
2025
Q4 | $633K | Sell |
1,935
-5
| -0.3% | -$1.59K | 0.09% | 107 |
|
|
2025
Q3 | $547K | Buy |
1,940
+14
| +0.7% | +$4.06K | 0.08% | 120 |
|
|
2025
Q2 | $538K | Sell |
1,926
-114
| -6% | -$32.3K | 0.08% | 121 |
|
|
2025
Q1 | $635K | Sell |
2,040
-110
| -5% | -$32.5K | 0.11% | 99 |
|
|
2024
Q4 | $560K | Buy |
2,150
+6
| +0.3% | +$1.78K | 0.1% | 111 |
|
|
2024
Q3 | $691K | Buy |
2,144
+50
| +2% | +$16.4K | 0.12% | 98 |
|
|
2024
Q2 | $654K | Sell |
2,094
-75
| -3% | -$22K | 0.12% | 93 |
|
|
2024
Q1 | $617K | Buy |
2,169
+84
| +4% | +$24.6K | 0.11% | 102 |
|
|
2023
Q4 | $601K | Sell |
2,085
-198
| -9% | -$53.9K | 0.11% | 102 |
|
|
2023
Q3 | $614K | Sell |
2,283
-37
| -2% | -$9.23K | 0.14% | 85 |
|
|
2023
Q2 | $515K | Buy |
2,320
+114
| +5% | +$26.5K | 0.11% | 100 |
|
|
2023
Q1 | $533K | Sell |
2,206
-153
| -6% | -$37.6K | 0.12% | 93 |
|
|
2022
Q4 | $620K | Buy |
2,359
+185
| +9% | +$49.6K | 0.13% | 94 |
|
|
2022
Q3 | $490K | Sell |
2,174
-56
| -3% | -$13.6K | 0.13% | 86 |
|
|
2022
Q2 | $544K | Buy |
2,230
+46
| +2% | +$11.3K | 0.14% | 82 |
|
|
2022
Q1 | $528K | Buy |
2,184
+6
| +0.3% | +$1.38K | 0.11% | 93 |
|
|
2021
Q4 | $490K | Buy |
2,178
+626
| +40% | +$132K | 0.1% | 98 |
|
|
2021
Q3 | $330K | Sell |
1,552
-155
| -9% | -$35.7K | 0.08% | 109 |
|
|
2021
Q2 | $416K | Buy |
1,707
+71
| +4% | +$17.5K | 0.1% | 94 |
|
|
2021
Q1 | $407K | Sell |
1,636
-223
| -12% | -$53.2K | 0.1% | 102 |
|
|
2020
Q4 | $427K | Buy |
1,859
+100
| +6% | +$23.1K | 0.12% | 95 |
|
|
2020
Q3 | $447K | Buy |
1,759
+2
| +0.1% | +$495 | 0.15% | 78 |
|
|
2020
Q2 | $414K | Sell |
1,757
-144
| -8% | -$32.9K | 0.16% | 65 |
|
|
2020
Q1 | $385K | Sell |
1,901
-1,684
| -47% | -$368K | 0.21% | 67 |
|
|
2019
Q4 | $864K | Buy |
3,585
+46
| +1% | +$10.1K | 0.37% | 45 |
|
|
2019
Q3 | $685K | Sell |
3,539
-16
| -0.5% | -$3.07K | 0.31% | 49 |
|
|
2019
Q2 | $655K | Buy |
3,555
+101
| +3% | +$18.1K | 0.3% | 49 |
|
|
2019
Q1 | $656K | Sell |
3,454
-384
| -10% | -$73.3K | 0.31% | 50 |
|
|
2018
Q4 | $747K | Sell |
3,838
-223
| -5% | -$43.5K | 0.33% | 50 |
|
|
2018
Q3 | $842K | Sell |
4,061
-534
| -12% | -$105K | 0.37% | 50 |
|
|
2018
Q2 | $848K | Buy |
4,595
+279
| +6% | +$49.4K | 0.35% | 46 |
|
|
2018
Q1 | $736K | Sell |
4,316
-2,708
| -39% | -$497K | 0.62% | 20 |
|
|
2017
Q4 | $1.22M | Sell |
7,024
-115
| -2% | -$20.4K | 0.96% | 14 |
|
|
2017
Q3 | $1.33M | Buy |
7,139
+173
| +2% | +$30.7K | 1.07% | 12 |
|
|
2017
Q2 | $1.2M | Buy |
6,966
+195
| +3% | +$31.7K | 1.11% | 11 |
|
|
2017
Q1 | $1.11M | Buy |
+6,771
| New | +$1.13M | 1.01% | 15 |
|
Other funds holding AMGN
VCM
VPM
CFO4Life Group's AMGN Position: Q1 2026 in Review
CFO4Life Group reduced its Amgen (AMGN) stake by 33% in Q1 2026, selling an estimated $224K and leaving 1,306 shares worth $459K. The position accounts for 0.07% of the portfolio, ranked #129.
CFO4Life Group first reported a position in AMGN in Q1 2017 and has held it in 37 quarters since. The position peaked at $1.33M in Q3 2017. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- CFO4Life Group held 1,306 shares of Amgen worth $459K as of Q1 2026.
- CFO4Life Group sold 629 Amgen shares in Q1 2026, an estimated $224K.
- Amgen made up 0.07% of CFO4Life Group's portfolio in Q1 2026, its #129 holding.
- CFO4Life Group first reported a position in Amgen in Q1 2017 and has held it in 37 quarters since.
- CFO4Life Group's Amgen position peaked at $1.33M in Q3 2017.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on CFO4Life Group's 13F filing for Q1 2026, filed 11 May 2026.